Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 30 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

27%

8 trials in Phase 3/4

Results Transparency

20%

5 of 25 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (6)
P 1 (4)
P 2 (6)
P 3 (5)
P 4 (3)

Trial Status

Completed25
Unknown3
Withdrawn1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07011147Not ApplicableRecruiting

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT00690066Phase 2Completed

PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

NCT05168657Not ApplicableCompleted

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

NCT02814838Phase 2CompletedPrimary

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

NCT00357890Not ApplicableCompletedPrimary

Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)

NCT04689685CompletedPrimary

The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes

NCT04078308Phase 1Unknown

Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients

NCT01236365Phase 3CompletedPrimary

Statins in Children With Type 1 Diabetes and Hypercholesterolemia

NCT01338922Not ApplicableCompletedPrimary

Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM)

NCT00014911Phase 2CompletedPrimary

Islet Transplantation for Type 1 Diabetes

NCT00297635Phase 2Withdrawn

Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy

NCT00069615Phase 4CompletedPrimary

Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children

NCT00166673Phase 2CompletedPrimary

Pilot Study of the Navigator Continuous Glucose Monitor

NCT00069628Phase 4CompletedPrimary

Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer

NCT00069537Phase 4CompletedPrimary

Continuous Glucose Monitors for Children With Diabetes Mellitus

NCT00044408Phase 3Completed

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

NCT00115570Phase 3CompletedPrimary

Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

NCT00005539Completed

Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes

NCT00035750Completed

Risk Factors for Atherogenesis in Type 1 Diabetes

NCT00005754Completed

Coronary Artery Calcification in Type 1 Diabetes

Scroll to load more

Research Network

Activity Timeline